EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

Editorial

Infliximab treatment of pediatric refractory Crohn’s disease: A case report

Sezin AŞIK AKMAN ¹ , Çiğdem ARIKAN ² , Gülben SÖZEN ¹ , Can ÖZTÜRK ¹ , Raşit Vural YAĞCI ³

Author Affiliation(s)

1.

Department of Pediatric Gastroenterology, Hepatology and Nutrition Unit, Tepecik Teaching Hospital, İzmir

2.

Departments of Pediatric Gastroenterology, Hepatology and Nutrition, Ege University School of Medicine, İzmir

3.

Department of Pediatric Gastroenterology, Ege University School of Medicine, İzmir

Turk J Gastroenterol 2006; 17: 133-136

Keywords : Crohn’s disease, childhood, infliximab

Read: 1537 Downloads: 1333 Published: 25 July 2019

Volume 17, Issue 2, June 2006

Previous Article

Files